State Street Corp Pet Vivo Holdings, Inc. Transaction History

State Street Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.63 $682 - $1,380	-525 Reduced 1.12%	46,229 $73,000
Q1 2022 May 16, 2022	BUY	$1.25 - $3.97 $442 - $1,405	354 Added 0.76%	46,754 $95,000
Q4 2021 Feb 14, 2022	BUY	$2.4 - $5.01 $111,360 - $232,464	46,400 New	46,400 $175,000

Ticker PETV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,072,000
Market Cap $4.73M
Description
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint affliction...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.